SRRA
Price:
$54.99
Market Cap:
$0
Sierra Oncology, Inc., a late-stage biopharmaceutical company, engages in researching, developing, and commercializing therapies for the treatment of patients with hematology and oncology needs. Its lead drug candidate, momelotinib, is a selective and orally bioavailable Janus kinase 1 (JAK 1), JAK2, and Activin A receptor type 1 (ACVR1) inhibitor. The company also develops SRA515, a selective bromodomain-containing protein 4 inhibitor; and SRA737, an orally bioavailable small molecule inhibitor of Checkpoint kinase 1. It has the license agreements with Carna Biosciences, Inc. to develop and commercialize SRA141, a small molecule kinase inhibitor targeting Cdc7; AstraZeneca AB; and CRT Pione...[Read more]
Industry
Biotechnology
IPO Date
2015-07-16
Stock Exchange
NASDAQ
Ticker
SRRA
According to Sierra Oncology, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -103896000.00. This represents a change of -156.24% compared to the average of 184.72M of the last 4 quarters.
The mean historical Enterprise Value of Sierra Oncology, Inc. over the last ten years is 5.59M. The current -103896000.00 Enterprise Value has changed -185824.39% with respect to the historical average. Over the past ten years (40 quarters), SRRA's Enterprise Value was at its highest in in the December 2021 quarter at 228.18M. The Enterprise Value was at its lowest in in the September 2015 quarter at -121784632.72.
Average
5.59M
Median
-4426048.69
Minimum
-129014204.35
Maximum
184.22M
Discovering the peaks and valleys of Sierra Oncology, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 2.81%
Maximum Annual Enterprise Value = 184.22M
Minimum Annual Increase = -232.87%
Minimum Annual Enterprise Value = -129014204.35
| Year | Enterprise Value | Change |
|---|---|---|
| 2021 | 184.22M | 184.50% |
| 2020 | 64.75M | -160.48% |
| 2019 | -107063882.05 | 1.28% |
| 2018 | -7779256.00 | -109.07% |
| 2017 | 85.78M | -232.87% |
| 2016 | -64556871.22 | -49.96% |
| 2015 | -129014204.35 | 2.81% |
| 2014 | -4426048.69 | -115.56% |
The current Enterprise Value of Sierra Oncology, Inc. (SRRA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
47.30M
5-year avg
43.98M
10-year avg
5.59M
Sierra Oncology, Inc.’s Enterprise Value is less than CinCor Pharma, Inc. (1.14B), less than POINT Biopharma Global Inc. (1.05B), less than EQRx, Inc. (650.25M), less than CTI BioPharma Corp. (1.22B), less than VectivBio Holding AG (848.58M), less than Gracell Biotechnologies Inc. (5.73B), less than Ethzilla Corp. (631.78M), less than Verve Therapeutics, Inc. (966.13M), less than Albireo Pharma, Inc. (677.78M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 1.14B | $1.27B | |
| 1.05B | $1.33B | |
| 650.25M | $1.14B | |
| 1.22B | $1.20B | |
| 848.58M | $1.06B | |
| 5.73B | $989.87M | |
| 631.78M | $188.33M | |
| 966.13M | $994.04M | |
| 677.78M | $915.89M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sierra Oncology, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Sierra Oncology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Sierra Oncology, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Sierra Oncology, Inc. (SRRA)?
What is the 3-year average Enterprise Value for Sierra Oncology, Inc. (SRRA)?
What is the 5-year average Enterprise Value for Sierra Oncology, Inc. (SRRA)?
How does the current Enterprise Value for Sierra Oncology, Inc. (SRRA) compare to its historical average?